000462287 000__ 01183cam\a2200337Ia\4500
000462287 001__ 462287
000462287 005__ 20210513161956.0
000462287 006__ m\\\\\\\\d\\\\\\\\
000462287 007__ cr\cn|||||||||
000462287 008__ 110909s2012\\\\njua\\\\sb\\\\001\0\eng\d
000462287 010__ $$z  2011037554
000462287 020__ $$z9781118185544
000462287 020__ $$z9780470587195
000462287 035__ $$a(CaPaEBR)ebr10560698
000462287 035__ $$a(OCoLC)797855333
000462287 040__ $$aCaPaEBR$$cCaPaEBR
000462287 05014 $$aRM301.42$$b.T44 2012eb
000462287 08204 $$a615.1/9$$223
000462287 24500 $$aTherapeutic targets$$h[electronic resource] :$$bmodulation, inhibition, and activation /$$cedited by Luis M. Botana, Mabel Loza.
000462287 260__ $$aHoboken, N.J. :$$bJohn Wiley & Sons,$$cc2012.
000462287 300__ $$axii, 482 p. :$$bill.
000462287 504__ $$aIncludes bibliographical references and index.
000462287 506__ $$aAccess limited to authorized users.
000462287 650_0 $$aDrugs$$xDesign.
000462287 650_0 $$aPharmaceutical industry.
000462287 655_7 $$aElectronic books.$$2lcsh
000462287 7001_ $$aBotana, Luis M.
000462287 7001_ $$aLoza, Mabel.
000462287 852__ $$bebk
000462287 85640 $$3ProQuest Ebook Central Academic Complete$$uhttps://univsouthin.idm.oclc.org/login?url=http://site.ebrary.com/lib/usiricelib/Doc?id=10560698$$zOnline Access
000462287 909CO $$ooai:library.usi.edu:462287$$pGLOBAL_SET
000462287 980__ $$aEBOOK
000462287 980__ $$aBIB
000462287 982__ $$aEbook
000462287 983__ $$aOnline